可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]金彦彦,马长生.不同年龄段急性冠状动脉综合征患者的危险因素、冠状动脉病变特点及预后分析[J].中国介入心脏病学杂志,2009,17(1):28-31.
[2]Grobbee DE,Bots ML.Statin treatment and progression of atherosclerotic plaque burden[J].Drugs,2003,63(9):893-911.
[3]Rosenson RS. statins in atherosclerosis:lipid-lowering agents with antioxidant capabilities[J].Atherosclerosis,2004,173(1):1-12.
[4]康俊萍,马长生.非ST段抬高和ST段抬高心肌梗死患者介入结果的比较[J].中华急诊医学杂志,2010,20(19):11-25.
[5]Morishima I,Sone T,Okumura K,et al.Agiographic no reflow phenomenon as a predictor of adverse long term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J].J Am Coll Cardiol,2000, 36(4):1202-1209.
[6]Tanaka A,Kawarahayashi T,Nishibori Y,et al.No reflow phenomenon and lesion morphology in patiens with acute myocardial infarction[J].Ciuculation,2001,105(6):2148-2152.
[7]Grube E,Gerckens U,Yeung AC,et al.Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection[J].Circulation,2001,104(20):2436-2441.
[8]Gaspardone A,Crea F,Versaci F,et al. Predictive Value of C-reactive Protein after successful coronary-artery stentingin patients With stable angina[J].Am Heart J,1998,82(15):515-518.
[9]Lamm G,Auer J,weber T,et al.Cardior asscular risk factor profiles and angiography results in young patients[J].Acta Med Austriaca, 2003,30(3):72-75.
[10]Katus HA,Remppis A,Scheffold T,et al.Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction[J].Am J Cardiol,1991,67(16):1360-1367.
[11]郁本洁.冠状动脉心脏病的近代观点[J].临床荟萃,1997,12(8):379-384.
[12]陈纪林.冠心病介入治疗并发症的防治[M].北京:人民卫生出版社,2010:52-53.